Generic insulin, cancer therapies? They’re coming

Feb 10th 2012. The Food and Drug Administration issued draft rules that will open the U.S. marketplace to “biosimilars” — essentially generic versions of medications made with living, often bioengineered, organisms.

Posted in Drugs